Kohl Cynthia, Aung Thiha, Haerteis Silke, Ignatov Atanas, Ortmann Olaf, Papathemelis Thomas
Department of Gynecology and Obstetrics, St. Marien Hospital Amberg, 92224, Amberg, Germany.
Institute for Molecular and Cellular Anatomy, University of Regensburg, 93053, Regensburg, Germany.
J Cancer Res Clin Oncol. 2022 May;148(5):1033-1043. doi: 10.1007/s00432-022-03936-z. Epub 2022 Feb 5.
We aimed to evaluate the role of the chorioallantoic membrane model (CAM) in breast cancer research.
The following is an overview of the use of the CAM in the field of breast cancer research based on a PubMed literature query.
The CAM is a 3D in vivo model that can be used for the analysis of tumor growth, biology and angiogenesis of primary tumor tissue or tumor cell lines. The CAM model has been used in breast cancer research for drug testing, migration assays and the evaluation of vascularization, amongst others. The CAM model is a valuable method that offers a better imitation of the physiological phenomena compared to 2D or 3D in vitro models.
The CAM model has primarily and successfully been utilized for the assessment of the tumor biology of established breast cancer cell lines. Further, the CAM model is a promising method to analyze patient derived primary tumor material and could be used as a "patient-specific 3D-tumor-therapy-model" for the cost-efficient evaluation of anti-cancer drugs to find the optimal treatment for breast cancer patients.
我们旨在评估绒毛尿囊膜模型(CAM)在乳腺癌研究中的作用。
以下是基于PubMed文献查询对CAM在乳腺癌研究领域应用的概述。
CAM是一种三维体内模型,可用于分析原发性肿瘤组织或肿瘤细胞系的肿瘤生长、生物学特性和血管生成。CAM模型已用于乳腺癌研究中的药物测试、迁移分析和血管化评估等。与二维或三维体外模型相比,CAM模型是一种有价值的方法,能更好地模拟生理现象。
CAM模型主要且成功地用于评估已建立的乳腺癌细胞系的肿瘤生物学特性。此外,CAM模型是分析患者来源的原发性肿瘤材料的一种有前景的方法,可作为“患者特异性三维肿瘤治疗模型”,用于经济高效地评估抗癌药物,为乳腺癌患者找到最佳治疗方案。